Illness	Number of cases
Chronic ischaemic heart disease (I25.13)	175
Left ventricular failure unspecified (I50.13)	174
Left ventricular failure unspecified (I50.14)	98
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	91
Volume depletion (E86)	90
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	74
Chronic ischaemic heart disease (I25.12)	61
Heart failure (I50.01)	58
Syncope and collapse (R55)	58
Unstable angina (I20.0)	53

Top 10 treatments

Treatment	Number
Complex differential diagnostic sonography of the vascular system with quantitative evaluation (3-035)	669
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	491
Additional information on materials used (8-83b.0c)	449
(9-984.8)	399
Examination of the left side of the heart with a tube (catheter) inserted into the heart via an artery (1-275.0)	327
(9-984.7)	326
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	285
Treatment of the heart and/or the coronary arteries with access through a tube (catheter) along the blood vessels (8-837.00)	268
Additional information on materials used (8-83b.bx)	250
Taking a tissue sample (biopsy) of the upper digestive tract, biliary tract or the pancreas by endoscopy (1-440.9)	235

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
35	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
27	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
25	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility